FORMULATION OF ANDROGRAPHOLIDE TRANSFERSOMES GEL FOR TRANSDERMAL DELIVERY: A PRELIMINARY STUDY by SURINI, SILVIA et al.
International Journal of Applied Pharmaceutics
ISSN - 0975 - 7058 Vol 12, Special Issue 1, 2020
 
ABSTRACT
Objective: A transfersome is a drug delivery system that offers increased penetration for the transdermal delivery of drugs. The aim of this study was 
to assess the application of transfersomes for transdermal delivery of andrographolide.
Methods: The development of andrographolide transfersomes for transdermal delivery was conducted in two steps. The first step involved varying 
ratios of Span 80 and phospholipids to investigate the effect on transfersome deformability using four formulations (P1–P4). Afterward, a second step 
involved varying ratios of andrographolide in transfersomes to investigate the influence on entrapment efficiency using four formulations (F1–F4). 
The selected transfersomes were then formulated into a gel dosage form. An in vitro penetration study was conducted by comparing the penetration 
fluxes of the transfersome and non-transfersome andrographolide gels using Franz diffusion cells.
Results: The results showed that formulation F4 had an entrapment efficiency of 97.02±0.01% and particle size (DV-average) of 524.02 nm. An in vitro 
penetration study of the andrographolide transfersome gels showed two phases of penetration, with a marked increase in both fluxes. In the first 
phase, penetration flux was 23.26±2.34 and 1.28±0.82 µg/cm2·h for the transfersome and non-transfersome andrographolide gels, respectively.
Conclusion: The results showed that the transfersome gel is a promising dosage system for transdermal delivery of andrographolide.
Keywords: Andrographolide, Transfersome, Franz diffusion cell, Penetration study.
INTRODUCTION
Andrographolide is the main chemical constituent of the stem and 
leaves of Andrographis paniculata. The leaves of A. paniculata are 
traditionally orally consumed to relieve symptoms of the common cold, 
fever, and irregular bowel movement [1], and are also used as a patch 
to cover scars and prevent infection [1]. In addition, recent studies have 
reported the anticancer effects of andrographolide [2].
In a previous study, andrographolide was characterized as having 
a low absolute oral bioavailability of 2.67%. Andrographolide is 
extensively metabolized in the duodenum and jejunum, and less so in 
the ileum and colon. The metabolism process results in an inactivated 
and sulfated form of andrographolide. High concentrations of sulfated 
andrographolide metabolites have been found in the liver, indicating 
extensive liver metabolism. At high doses, the oral bioavailability of 
andrographolide is hindered by its poor absorption in the terminal 
ileum and colon due to the presence of efflux transporters. About 5% 
of orally administered andrographolide is also excreted through bile, 
which further complicates the oral bioavailability of andrographolide. 
Taken together, oral administration of andrographolide at both low and 
high concentrations results in poor absolute oral bioavailability [3].
Transdermal delivery offers an alternative for the administration 
of andrographolide, which improves metabolism and absorption as 
compared with oral delivery. However, transdermal delivery may be 
hindered due to the low partition coefficient of andrographolide (log 
papp=0.59 in the water at 37°C) [4,5].
A transfersome is an artificial vesicle with the ability to change its shape 
and size to fit into much smaller spaces without rupturing to enhance 
the capability of an active ingredient to penetrate through the skin [6,7]. 
In recent studies, transfersomes were applied to enhance the delivery 
of large molecular or highly hydrophobic drugs across the skin. The aim 
of the present study was to investigate the application of transfersomes 
for the delivery of andrographolide.
METHODS
Materials
Andrographolide (98%) was purchased from Xi’an Lyphar Biotech Co. 
Ltd. (Xi’an City, China). Phospholipon 90 G was acquired from Lipoid 
GmbH (Ludwigshafen am Rhein, Germany). Sprague Dawley rats were 
obtained from Institut Pertanian Bogor (Bogor Agricultural University, 
Bogor, Indonesia). Other chemicals and solvents were of analytical 
grade and purchased from commercial suppliers.
Optimization and evaluation of andrographolide transfersomes
An optimization study was conducted to select the most suitable 
ratio of phospholipid and Span 80 based on the deformability index. 
Andrographolide transfersome formulations P1–P4 were prepared 
with the use of the thin-film hydration method [8]. All transfersome 
formulations contained solid transfersomes at a concentration of 
5 g/100 mL, with a ratio of andrographolide to phospholipid-Span 80 
of 1:2 and a ratio of phospholipid to Span 80 of 95:5 (P1), 90:10 (P2), 
85:15 (P3), or 80:20 (P4), as shown in Table 1.
Andrographolide, phospholipids, and Span 80 were dissolved in methanol 
by stirring at 200 rpm for 20 min. The solution was then transferred 
into a round-bottomed flask and evaporated using a rotary evaporator 
(Buchi model R-100; Buchi AG, Flawil, Switzerland) at 45±20°C under 
lowered pressure with stirring at 125 rpm. After all of the solvents were 
evaporated and a thin layer had formed on the walls of the flask, nitrogen 
gas was flowed into the flask for 2 min. The flask was then refrigerated for 
24 h. Afterward, the thin layer was hydrated for 45 min with phosphate 
buffer (pH 7.4) at 40°C with constant stirring at 125 rpm.
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The deformability index was evaluated using the extrusion method [9]. 
Transfersomes were extruded using a Mini Extruder Kit (Avanti 
Polar Lipids Inc., Alabaster, AL, USA) through a membrane (pore size, 
450 nm) for 5 min. The amount of transfersomes that were able to 
pass through the membrane was recorded and the particle size was 












where, D=Deformability of the vesicle membrane, J=The amount 
of suspension extruded over a period of 5 min, rv=Vesicle size after 
extrusion, and rp=Pore size of the barrier [10].
The particle size was also measured using a particle size analyzer 
(Malvern Zetasizer; Malvern Instruments, Malvern UK) in a 
suspension of one drop of transfersomes in 10 ml of phosphate buffer 
(pH 7.4) [7,11,12]. The zeta potential was measured by testing one drop 
of transfersomes in 10 ml of distilled water using the same equipment.
Formulation and evaluation of andrographolide transfersomes
Based on the results of the optimization study, four formulations were 
prepared by the thin-film hydration method [8]. All transfersome 
formulations contained solid transfersomes at a concentration of 
5 g/100 mL, with a ratio of andrographolide to phospholipid-Span 80 of 
1:2 (F1), 1:5 (F2), 1:10 (F3), or 1:15 (F4), as shown in Table 2.
Andrographolide, phospholipids, and Span 80 were dissolved in 
methanol by stirring at 200 rpm for 20 min. The solution was then 
transferred into a round-bottomed flask and evaporated using a rotary 
evaporator (R-100) equipped with a vacuum pump (model V-100; 
Buchi AG) at 45±20°C at a lowered pressure with stirring at 125 rpm. 
After all of the solvents were evaporated and a thin layer had formed 
on the walls of the flask, nitrogen gas was flowed into the flask for 
2 min. The flask was then refrigerated for 24 h. Afterward, the thin layer 
was hydrated for 45 min using phosphate buffer (pH 7.4) at 40°C with 
constant stirring at 125 rpm.
Entrapment efficiency was evaluated using the direct method. 
Andrographolide transfersomes were separated from unentrapped 
andrographolide by centrifugation (CP100WX Ultracentrifuge; Hitachi 
High-Technologies Corporation, Tokyo, Japan) at 10,000 rpm for 
60 min. The precipitate was separated from the filtrate by decantation 
and washed 2 times with phosphate buffer (pH 7.4). The precipitate 
containing andrographolide transfersomes was reconstituted with 
methanol and shaken until properly diluted. The resulting solution was 
filtered through a filter with a pore size of 0.45 µm. Andrographolide in 
the transfersomes was quantified with the use of a high-performance 
liquid chromatography system [13,14] (model LC-20AT; Shimadzu 
Corporation, Kyoto, Japan) equipped with an ultraviolet (UV) 
absorbance detector (model SPD-20A; Shimadzu Corporation) at 
223 nm. A C18 column was used as the stationary phase, whereas the 
mobile phase was methanol-water at a ratio of 65:35. The flow rate for 
the analysis was 1.0 mL/min.
The particle size in one drop of transfersomes in 10 ml of phosphate 
buffer (pH 7.4) [7,11,12] was measured using a particle size analyzer 
(Malvern Zetasizer). Transfersome morphology was evaluated using a 
transmission electron microscope (TEM) (200 kV FEI Tecnai F20 Super-
Twin; Thermo Fisher Scientific, Waltham, MA, USA). The transfersome 
suspension was negatively stained by placing one drop on a carbon-
coated grid and adding one drop of 1% phosphotungstic acid. Any excess 
liquid was removed and the sample was examined using a TEM [11].
Formulation and evaluation of the andrographolide transfersome gel
The gel base was formulated by thoroughly dispersing 750 mg of 
carbomer (Carbopol® Ultrez 30 polymer; Lubrizol Corporation, Wickliffe, 
OH, USA) [12] in distilled water. Then, 500 mg of triethanolamine was 
added until a mass had formed. Afterward, 12.5 g of propylene glycol was 
added, followed by 50 ml of andrographolide transfersomes (equivalent 
to 150 mg of andrographolide). A control gel was formulated by dissolving 
150 mg of andrographolide in a mixture of methanol and phosphate buffer 
(pH 7.4) into the gel base. Both andrographolide gels were evaluated for 
physical appearance, pH (H 510 microprocessor-based benchtop meter; 
Eutech Instruments Pte Ltd., Singapore), and viscosity (Brookfield 
viscometer; AMETEK Brookfield, Middleborough, MA, USA).
In vitro penetration study
In vitro penetration capabilities were examined using Franz diffusion 
cells (Mitra Cellular, Bali, Indonesia) [12]. The abdominal skin of 
rats (age, 8–10 weeks; weight, ~200 g) was used as a membrane 
for the penetration study. The methods used for animal sacrifice 
were approved by the Ethical Clearance Committee of Dr. Cipto 
Mangunkusumo Hospital, Faculty of Medicine, Universitas Indonesia 
(approval no. 0447/UN2.FI/ETIK/2018).
The Franz diffusion cell receptor compartment contained 10% methanol 
solution in phosphate buffer (pH 7.4) and was constantly stirred at 
250 rpm at 37±20°C. Samples (2 ml) were collected periodically over a 
24-h period. The amount of penetrated andrographolide was quantified 
using a high-performance liquid chromatography system equipped 
with a UV absorbance detector at 223 nm, as described above and 
elsewhere [13,14]. A C18 column was used as the stationary phase with 
a mobile phase of methanol-water at a ratio of 65:35. The flow rate for 
analysis was 1.0 ml/min.
RESULTS
Optimization and evaluation of andrographolide transfersomes
Transfersome formulations P1–P4 were opaque white in appearance 
and tended to settle on long-term storage. However, it was easy to 
re-disperse the sediments. The deformability study indicated that 
P4 had the highest deformability (Table 3). The particle sizes of the 
andrographolide transfersomes and the related zeta potentials are 
shown in Table 4. An increase in particle size was associated with an 
increase in the concentration of Span 80.
Formulation and evaluation of andrographolide transfersomes
Transfersomes F1–F4 formed colloidal dispersions that were white in 
color. Similar to the optimized formulations, the transfersomes tended 
to settle upon long-term storage, but were able to be re-dispersed.
The entrapment efficiency and particle size of formulations F1–F4 are 
shown in Table 5. The entrapment efficiency was in the range of 46.62–
97.02%. Among the four formulations, F1 had the lowest entrapment 
efficiency and F4 had the highest.
Table 1: Formula optimization of andrographolide 
transfersomes
Materials Ratio (g)
P1 P2 P3 P4
Andrographolide 1.67 1.67 1.67 1.67
Phospholipid 3.17 3.00 2.83 2.67
Span 80 0.17 0.33 0.50 0.67
Phosphate buffer pH 7.4 ad 100 ad 100 ad 100 ad 100
Table 2: Formulations of andrographolide transfersomes
Materials Ratio (g)
F1 F2 F3 F4
Andrographolide 1.67 0.83 0.45 0.31
Phospholipid 2.67 3.33 3.64 3.75
Span 80 0.67 0.83 0.91 0.94
Phosphate buffer pH 7.4 ad 100 ad 100 ad 100 ad 100
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Table 3: Deformability index of the optimized andrographolide transfersome formulations
Formula Amount of extruded 
transfersomes (mL)





P1 0.09 571.33 48.2 0.0010
P2 0.34 2098.73 50.9 0.0044
P3 0.19 612.70 57.9 0.0032
P4 0.45 625.00 136.9 0.0417
Table 4: Particle size and zeta potential measurements of the optimized andrographolide transfersomes
Formula DV‑10 (nm) DV‑50 (nm) DV‑90 (nm) DV‑averge (nm) Zeta Potential (mV)
P1 77.23 377.67 571.33 339.96 −0.21
P2 85.47 112.60 2098.73 5400.00 −6.17
P3 391.30 443.30 612.70 498.01 −10.70
P4 403.00 502.75 625.00 507.32 −6.39
Table 5: Measurements of particle sizes and entrapment efficiency of andrographolide transfersomes
Formula DV‑10 (nm) DV‑50 (nm) DV‑90 (nm) DV‑average (nm) PDI EE (%)*
F1 616 825 1100 842.49 0.61 46,62±0,01
F2 460 639 1910 845.29 0.86 55,77±0,01
F3 524 762 5560 1941.58 0.95 59,16±0,03
F4 405 516 668 524.02 1.00 97,02±0,01
*(mean±standard deviation, n=3), PDI: Polydispersity index
Transfersome size was relatively large, with a high polydispersity 
index (PDI). The transfersome particle sizes and distribution patterns 
are shown in Fig. 1. Andrographolide transfersomes were spherical in 
shape, as shown in Fig. 2.
Formulation and evaluation of the andrographolide transfersome gel
Gels containing andrographolide transfersomes were opaque white in 
color. The pH of the gels was rather acidic at 5.86, and the viscosity was 
60,000 cps. On the other hand, non-transfersome andrographolide gels 
were almost transparent in color with a slightly elevated pH of 6.38 and 
an elevated viscosity of 68,000 cps.
In vitro penetration study
Andrographolide transfersome gels showed two distinct phases of 
penetration. Gels containing andrographolide transfersomes showed a 
burst effect in an in vitro penetration study at 2.5 min. The flux of the 
first phase was 23.258 µg/cm2·h and lasted for 1 h. The flux over the 
next hour had increased to 24 h 2.708 µg/cm2·h.
Comparatively, non-transfersome andrographolide gels also had two 
phases, an initial flux of 1.280 µg/cm2·h for the first 3 h and a second 
flux of 0.327 µg/cm2·h until 24 h. The penetration profiles of both 
andrographolide gels are shown in Fig. 3 and the results of a comparison 
of the flux of both andrographolide gels are shown in Fig. 4.
DISCUSSION
Optimization and evaluation of andrographolide transfersomes
Transfersomes were prepared by thin-film hydration, which is widely 
used in many studies, as this method is relatively easy to conduct in 
the laboratory setting [11,12,15]. Optimized formulations contained 
andrographolide and transfersomes at a 1:2 ratio. Formulations were 
prepared using the surfactant Span 80 because its hydrophobicity 
is pharmaceutically compatible with that of andrographolide, which 
could benefit entrapment efficiency [8].
A phosphate buffer at pH 7.4 was chosen as the hydrating solution in 
this study to achieve favorable transdermal delivery of andrographolide. 
Phosphatidylcholine has an isoelectric point between 6 and 7. Due to 
the more basic nature of phosphate buffer, phosphatidylcholine has a 
net negative charge. The negative charge of transfersomes facilitates 
the transdermal delivery of andrographolide and other drugs [16].
Deformability index is an important characteristic of transfersomes 
reflecting the ability to transverse the stratum corneum and still retain 
the shape. The surfactant concentration in the transfersome formulations 
has been shown to affect the deformability of transfersomes by increasing 
plasticity [8]. Accordingly, the concentration of Span 80 in the transfersomes 
was chosen as a parameter in the optimization process. Formulations 
P1–P4 had increasing amounts of Span 80 in the phospholipid portion 
(5%, 10%, 15%, and 20%, respectively). The effect of the surfactant 
concentration on deformability is evidenced in the four formulation with 
F4 having the highest deformability and F1 having the lowest.
An increase in size was noted with an increase in the Span 80 
concentration. An increase in the concentration of Span 80 in the 
formulations tended to increase the size of the transfersomes, as 
indicated in a study by Gupta et al. [7]. The zeta potential of all 
formulations was in the negative ranges, which was due to the 
net negative charge of phosphatidylcholine in phosphate buffer at 
pH 7.4 [17].
Formulation and evaluation of andrographolide transfersomes
Andrographolide transfersomes were prepared by the thin-film 
hydration method. Formulations F1–F4 all contained 20% Span 80 in 
the phospholipid portion. An increase in the phospholipid content in 
transfersomes affects the entrapment efficiency of andrographolide. 
Hence, this phenomenon was further explored [6,8]. Formulations 
F1–F4 contained andrographolide in decreasing ratios in respect to 
phospholipid-Span 80 (1:2, 1:5, 1:10, and 1:15, respectively). The 
obtained transfersomes were milky white in color.
The entrapment efficiency of formulations F1–F4 had increased with 
an increase in the lipid content. F4 had the highest phospholipid-
andrographolide ratio, which resulted in remarkable entrapment 
efficiency. The entrapment efficiency of transfersomes will increase as 
more phospholipids are added into the formulation. The addition of 
lipids increased the rigidity of the transfersomes, which improved the 
efficiency of andrographolide encapsulation [6].
Furthermore, the addition of 20% Span 80 to the formulations proved 
to be beneficial. For example, Gupta et al. reported a maximum 
entrapment efficiency in transfersome formulations containing 20% 
surfactant. A further increase in the surfactant content had no effect on 
the entrapment efficiency of transfersomes [7].
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Transfersomes were large in size with a high polydispersity (PDI=0.61–
1.00). The tendency of transfersomes to settle on long-term storage 
indicates a low zeta potential that could affect size stability, leading to 
the formation of larger vesicles by fusing with one another. This could 
explain the polydispersity that was observed in formulations F1–F4. As 
a preventive measure to hinder the fusion of vesicles, the transfersomes 
were stored at 4°C because the fusogenicity of transfersomes seems to 
be influenced by storage temperature, where a higher temperature 
(e.g., 37°C) seems to increase the fusion of transfersomes [18].
The spherical morphology confirms the vesicular characteristics of 
andrographolide transfersomes. Morphologically, transfersomes do 
not tend to form multilamellar vesicles. The unilamellar spherical 
shape was formed due to the binding of the phosphatidylcholine 
heads of the molecules in the presence of water. This formation traps 
the hydrophobic andrographolide molecules in the lipophobic ends of 
phosphatidylcholine, thus encapsulating it and forming a vesicle.
Formulation and evaluation of the andrographolide transfersome gel
The white color of the andrographolide transfersome gel can be 
attributed to the white color of the transfersomes. The viscosity of 
the andrographolide transfersome gel is lower than that of non-
transfersome andrographolide gel because of the lower acidity. 
Viscosity is altered by the acidity of the gel because carbomer, the 
gelling agent of both andrographolide gels, favors a basic pH [19].
In vitro penetration study
The results of the in vitro penetration study showed that 
andrographolide was able to penetrate across the skin with or without 
transfersomes. However, there was a marked increase in penetration 
across skin with a gel containing andrographolide transfersomes, 
which was further evidenced by a marked increase in fluxes of 
penetration when compared to the control gel. These results show that 
encapsulation in transfersomes highly increased transdermal delivery 
of andrographolide.
The mechanism underlying transfersome transport of andrographolide 
through the skin can be explained by a difference in osmotic gradients 
between the stratum corneum (15% water content) and epidermis 
(75% water content). This difference provides a driving force for 
transfersomes to penetrate through the skin. This tendency is caused 
by innate characteristics of transfersomes to prevent dehydration and 
rupture. This transport is further assisted by deformability, which 
enables transport of transfersomes through the skin with minimal 
effects on the shape and size [18,20].
The two distinct phases in the penetration of andrographolide gel may 
have been due to the deposition of andrographolide on rat skin. Initially, 
andrographolide can rapidly penetrate through the skin, which indicates 
a release of a surface-absorbed drug. Afterward, andrographolide, both 
as free drug and as a transfersome, is deposited in the subcutaneous 
tissue, which acts as a reservoir that provides a slower, delayed drug 
release, thereby explaining the distinct penetration phase [18]. Further 
studies of andrographolide skin deposition are needed to confirm this 
hypothesis.
Another mechanism that could explain the two-phase penetration 
profile of andrographolide transfersome gel is the deceleration caused 
Fig. 1: Particle size distribution of andrographolide 
transfersomes (F1–F4)
Fig. 2: Morphology representation of andrographolide 
transfersomes of F1
Fig. 3: Penetration profiles of andrographolide gels. Blue dots 
indicate andrographolide transfersome gel and orange dots 
indicate non‑transfersome andrographolide gel
Fig. 4: Flux comparison of andrographolide gels. Blue bars 
indicate the flux of andrographolide transfersome gel and orange 
bars indicate the flux of non‑transfersome andrographolide gel
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by the heterogeneity of transfersome sizes. Due to the low deformability 
of andrographolide transfersomes, larger transfersome vesicles cannot 
cross the skin. It is also likely that the transport of larger transfersomes 
is hindered due to the physical characteristics of the vesicles [20].
CONCLUSION
Andrographolide transfersome formulation F4 resulted in vesicles with 
an entrapment efficiency of 97.02±0.01% with DV-average of 524.02 nm. 
The gel containing andrographolide transfersomes revealed a marked 
increase in penetration capability in vitro, as compared to the non-
transfersome andrographolide gel, suggesting that the andrographolide 
transfersome gel is a promising potential system for transdermal 
delivery of andrographolide. In addition, it is recommended that 
andrographolide transfersomes with more homogenous particle sizes 
and better deformability should be developed to ensure successful 
transdermal delivery of andrographolide.
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